Delaware top court will hear drugmakers' appeal to end Zantac lawsuits

Delaware's highest court said on Tuesday it will hear an appeal by GSK (GSK.L) and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.